Bookimed does not add extra charges for Aplastic anemia treatment prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your treatment upon your arrival to the country.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Aplastic anemia treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Aplastic anemia treatment journey.
The cost of aplastic anemia treatment can range from $50,850 to $134,100:
The doctor will determine the total treatment cost based on your needs and past treatments.
| Italy | Turkey | Austria | |
| Bone marrow transplantation | - | from $5,190 | - |
| Allogenic bone marrow transplantation from an unrelated donor | - | from $75,000 | - |
| Allogenic bone marrow transplantation from a related donor | - | from $65,000 | - |
Ospedale San Raffaele (San Raffaele Research Hospital) in Milan is one of the largest research hospitals in Europe. It applies ad hoc methods for rare immune system and genetic diseases treatment.
Among its achievements — the world's first stem cell therapy for patients with severe combined immune deficiency disorder (ADA-SCID).
Oncology, oncohematology, neurosurgery, neurology, cardiovascular surgery, urology, and gynecology are the strongest specialities here.
Surgeons of the hospital perform over 52,000 operations annually.
Professor Fabio Ciceri is the Head of the Hematology and Bone Marrow Transplantation Unit at San Raffaele Research Hospital and the Blood Transfusion Centre. He has over 180 papers published and has held various Medical and Teaching positions since 1989. He is a member of multiple organizations related to Hematology and was awarded a Merit Recognition Award at the University of Ferrara. He is a Principal Investigator in Cell and Gene Therapy clinical trials for haematological cancers, immune-deficiencies, and neuromuscular disorder.